Diagnosis and treatment of idiopathic thrombocytopenic purpura

American Family Physician

Volumn 54, Issue 8, 1996, Pages 2437-2447

  George, J N ^a   Woolf, S H ^a   Raskob, G E ^a   Wasser, J S ^a   Aledort, L M ^a   Ballem, P I ^a   Blanchette, V S ^a   Bussel, A B ^a   Cines, D B ^a   Kelton, J G ^a   Lichtin, A E ^a   McMillan, R ^a   Okerbloom, J A ^a   Regan, D H ^a   Warrier, I ^a  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; IMMUNOGLOBULIN G;

ANAMNESIS; ARTICLE; BLOOD CELL COUNT; BLOOD SMEAR; CLINICAL EXAMINATION; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOTHERAPY; MEDICAL SOCIETY; ORAL DRUG ADMINISTRATION; PARENTERAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; TREATMENT PLANNING;

DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC;

EID: 10544233015     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology. Blood 1996;88:3-40.
2. Kurata Y, Miyagawa S, Kosugi S, Kashiwagi H, Honda S, Mizutani H, et al. High-titer antinuclear antibodies, anti-SSA/Ro antibodies and antinuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura. Thromb Haemost 1994;71:184-7.
3. Stasi R, Stipa E, Masi M, Oliva F, Sciarra A, Perrotti A, et al. Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura. Blood 1994;84:4203-8.
4. George JN, El-Harake MA, Raskob GE. Chronic idiopathic thrombocytopenic purpura. N Engl J Med 1994;331:1207-11.
5. George JN, El-Harake MA, Aster RH. Thrombocytopenia due to enhanced platelet destruction by immunologic mechanisms. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, eds. Williams Hematology. 5th ed. New York: McGraw-Hill, 1995:1315-55.
6. Guthrie TH, Brannan DP, Prisant LM. Idiopathic thrombocytopenic purpura in the older adult patient. Am J Med Sci 1988;296:17-21.
7. Cortelazzo S, Finazzi G, Buelli M, Molteni A, Viero P, Barbui T. High risk of severe bleeding in aged patients with chronic idiopathic thrombocytopenic purpura. Blood 1991;77:31-3.
8. Burrows RF, Kelton JG. Fetal thrombocytopenia and its relation to maternal thrombocytopenia. N Engl J Med 1993;329:1463-6.
9. Burrows RF, Kelton JG. Pregnancy in patients with idiopathic thrombocytopenic purpura: assessing the risks for the infant at delivery. Obstet Gynecol Surv 1993;48(12):781-8.
10. Burrows RF, Kelton JG. Low fetal risks in pregnancies associated with idiopathic thrombocytopenic purpura. Am J Obstet Gynecol 1990;163:1147-50.
11. Cook DJ, Guyatt GH, Laupacis A, Sackett DL. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest 1992; 102:3055-115.
12. Daffos F, Capella-Pavlovsky M, Forestier F. Fetal blood sampling during pregnancy with the use of a needle guided by ultrasound: a study of 606 consecutive cases. Am J Obstet Gynecol 1985;153:655-60.
13. Garmel SH, Craigo SD, Morin LM, Crowley JM, D'Alton ME. The role of percutaneous umbilical blood sampling in the management of immune thrombocytopenic purpura. Prenat Diagn 1995; 15:439-45.
14. Lacey JV, Penner JA. Management of idiopathic thrombocytopenic purpura in the adult. Semin Thromb Hemost 1977;3:160-74.
15. McWilliams NB, Maurer HM. Acute idiopathic thrombocytopenic purpura in children. Am J Hematol 1979;7:87-96.
16. Buchanan GR, Holtkamp CA. Prednisone therapy for children with newly diagnosed idiopathic thrombocytopenic purpura. A randomized clinical trial. Am J Pediatr Hematol Oncol 1984;6(4):355-61.
17. Sartorius JA. Steroid treatment of idiopathic thrombocytopenic purpura in children. Preliminary results of a randomized cooperative study. Am J Pediatr Hematol Oncol 1984;6(2):165-9.
18. Blanchette VS, Luke B, Andrew M, Sommerviue-Nielsen S, Barnard D, de Veber B, et al. A prospective, randomized triai of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr 1993;123:989-95.
19. Blanchette V, Imbach P, Andrew M, Adams M, McMillan J, Wang E, et al. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura. Lancet 1994;344:703-7.
20. Jacobs P, Wood L, Novitzky N. Intravenous gammaglobulin has no advantages over oral corticosteroids as primary therapy for adults with immune thrombocytopenia: a prospective randomized clinical trial. Am J Med 1994;97:55-9.
21. Rasmus KT, Rottman RL, Kotelko DM, Wright WC, Stone JJ, Rosenblatt RM. Unrecognized thrombocytopenia and regional anesthesia in parturients: a retrospective review. Obstet Gynecol 1989;73;943-6.
22. Pearson HA. The spleen and disturbances of splenic function, In: Nathan DG, Oski FA, eds. Hematology of infancy and childhood. 4th ed. Philadelphia: Saunders, 1993:1058-77.
23. Najean Y, Lecompte T. Genetic thrombocytopenia with autosomal dominant transmission: a review of 54 cases. Br J Haematol 1990;74:203-8.
24. Halperin DS, Doyle JJ. Is bone marrow examination justified in idiopathic thrombocytopenic purpura? Am J Dis Child 1988;142:508-11.
25. Centers for Disease Control and Prevention. Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of vaccines and immune globulins in persons with altered immunocompetence. MMWR Morb Mortal Wkly Rep 1993;42:1-18.
26. Doan CA, Bouroncle BA, Wiseman BK. Idiopathic and secondary thrombocytopenic purpura: clinical study and evaluation of 381 cases over a period of 28 years. Ann Intern Med 1960;53:861-76.
27. McIntyre OR, Ebaugh FG. Palpable spleens in college freshmen. Ann Intern Med 1967;66:301-6.
28. Eyster ME, Rabkin CS, Hilgartner MW, Aledort LM, Ragni MV, Sprandio J, et al. Human immunodeficiency virus-related conditions in children and adults with hemophilia: rates, relationship to CD4 counts, and predictive value. Blood 1993;81:828-34.
29. Garcia Suarez J, Calero MA, Ricard MP, Krsnik I, Rus GP, Perera F, et al. EDTA-dependent pseudothrombocytopenia in ambulatory patients: clinical characteristics and role of new automated cell-counting in its detection. Am J Hematol 1992;39:146-8.
30. Najean Y, Lecompte T. Chronic pure thrombocytopenia in elderly patients: an aspect of the myelodysplastic syndrome. Cancer 1989;64:2506-10.